menu
    • menu

    Company profile for Mateon Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mateon Therapeutics is a biopharmaceutical company seeking to realize the full potential of vascular targeted therapy (VTT) in orphan oncology indications. VTTs include vascular disrupting agents (VDAs) such as the investigational drugs that Mateon is developing, and anti-angiogenic agents (AAs), a number of which are FDA approved and widely used in cancer treatment. These 2 approaches (VDAs and AAs) have distinct yet compleme...
    Mateon Therapeutics is a biopharmaceutical company seeking to realize the full potential of vascular targeted therapy (VTT) in orphan oncology indications. VTTs include vascular disrupting agents (VDAs) such as the investigational drugs that Mateon is developing, and anti-angiogenic agents (AAs), a number of which are FDA approved and widely used in cancer treatment. These 2 approaches (VDAs and AAs) have distinct yet complementary mechanisms of action. At Mateon, we believe that we can significantly improve cancer therapy by combining these 2 complementary approaches.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mateon TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    701 Gateway Boulevard, Suite 210 South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.mateon.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/mateon-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oncotelic CEO Vuong Presents TGFB2 Research at SWCR Conference
    Oncotelic CEO Vuong Presents TGFB2 Research at SWCR Conference

    13 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/13/3025821/0/en/Oncotelic-CEO-Vuong-Trieu-to-Present-Groundbreaking-Research-on-Transforming-Growth-Factor-Beta-2-TGFB2-at-SWCR-2025-Conference.html

    GLOBENEWSWIRE
    13 Feb 2025
    Share Share
    MATEON’S UPDATE ON C001 - GLOBAL STUDY FOR OT-101 AGAINST COVID-19
    MATEON’S UPDATE ON C001 - GLOBAL STUDY FOR OT-101 AGAINST COVID-19

    08 Mar 2021

    // GLOBENEWSWIRE

    http://www.globenewswire.com/news-release/2021/03/08/2188544/0/en/MATEON-S-UPDATE-ON-C001-GLOBAL-STUDY-FOR-OT-101-AGAINST-COVID-19.html

    GLOBENEWSWIRE
    08 Mar 2021
    Share Share
    MATEON’S GLOBAL STUDY FOR OT-101/ TGF-? INHIBITOR AGAINST COVID-19
    MATEON’S GLOBAL STUDY FOR OT-101/ TGF-? INHIBITOR AGAINST COVID-19

    30 Dec 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/12/30/2151812/0/en/MATEON-S-GLOBAL-STUDY-FOR-OT-101-TGF-%CE%B2-INHIBITOR-AGAINST-COVID-19-ENROLLS-AND-TREATS-ITS-FIRST-PATIENT.html

    GLOBENEWSWIRE
    30 Dec 2020
    Share Share
    FDA Granted Pediatric Disease Designation for OXi-4503
    FDA Granted Pediatric Disease Designation for OXi-4503

    16 Sep 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/09/16/2094584/0/en/FDA-Granted-Pediatric-Disease-Designation-for-OXi-4503.html

    GLOBENEWSWIRE
    16 Sep 2020
    Share Share
    Mateon and Asili Research Alliance Enter Into Partnership for the Development
    Mateon and Asili Research Alliance Enter Into Partnership for the Development

    20 Jul 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/mateon-and-asili-research-alliance-enter-into-partnership-for-the-development-of-artemisinin-against-covid-19/

    BIOSPACE
    20 Jul 2020
    Share Share
    Mateon Therapeutics to fund observational studies of Artemisinin
    Mateon Therapeutics to fund observational studies of Artemisinin

    13 Jul 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/07/13/2061115/0/en/Mateon-Therapeutics-to-fund-observational-studies-of-Artemisinin-in-developing-countries.html

    GLOBENEWSWIRE
    13 Jul 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search